Skip to main content
. Author manuscript; available in PMC: 2017 Apr 1.
Published in final edited form as: J Pediatr Gastroenterol Nutr. 2016 Apr;62(4):618–626. doi: 10.1097/MPG.0000000000001004

Table 4B. Placebo and. LXS Groups at Baseline and 12 Months.

Characteristics n Baseline 12 Months P1 P2
Age, yr
 Placebo 6 13.3 ± 1.1 14.3 ± 1.1
 LXS 8 12.6 ± 1.7 13.7 ± 1.8
MRS
Calf Choline, %
 Placebo 6 0.09 ± 0.01 0.09 ± 0.02 0.785 0.034
 LXS 8 0.09 ± 0.02 0.12 ± 0.04 0.005
Calf Lipid fraction, %
 Placebo 6 4.87 ± 1.97 5.83 ± 2.80 0.001 0.636
 LXS 8 3.87 ± 1.02 5.01 ± 1.08 <0.001
Liver lipid, %
 Placebo 6 5.01 ± 5.57 6.60 ± 6.52 0.100 0.993
 LXS 8 7.98 ± 8.54 9.60 ± 4.66 0.591